2024
Barriers in healthcare to the use of optical coherence tomography angiography in multiple sclerosis.
Reeß, L.G., Salih, H., Delikaya, M., Paul, F. and Oertel, F.C.
Neurology and Therapy
5 November 2024
(In Press)
2022
A response to: Letter to the editor regarding "Network meta-analysis of food and drug administration-approved treatment options for adults with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder".
Wingerchuk, D.M., Zhang, I., Kielhorn, A., Royston, M., Levy, M., Fujihara, K., Nakashima, I., Tanvir, I., Paul, F. and Pittock, S.J.
Neurology and Therapy
2 July 2022
Therapy switches in fingolimod-treated patients with multiple sclerosis: long-term experience from the German MS Registry.
Frahm, N., Fneish, F., Ellenberger, D., Flachenecker, P., Paul, F., Warnke, C., Kleinschnitz, C., Parciak, T., Krefting, D., Hellwig, K., Haas, J., Rommer, P.S., Stahmann, A. and Zettl, U.K.
Neurology and Therapy 11
(1): 319–336.
March 2022
Network meta-analysis of food and drug administration-approved treatment options for adults with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder.
Wingerchuk, D.M., Zhang, I., Kielhorn, A., Royston, M., Levy, M., Fujihara, K., Nakashima, I., Tanvir, I., Paul, F. and Pittock, S.J.
Neurology and Therapy 11
(1): 123-135.
March 2022
This list was generated on Sat Dec 21 05:00:31 2024 UTC.